| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
4
| Jordan Julie (Chief Medical Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 436 shares
@ $1.39, valued at
$606
Sold 109 shares
@ $1.39, valued at
$151.5
Sold 1,308 shares
@ $1.39, valued at
$1.8k
Exercised 1,548 restricted stock units
@ $0
Exercised 387 restricted stock units
@ $0
Exercised 4,644 restricted stock units
@ $0 |
|
| 08/04/2023 |
4
| Jordan Julie (Chief Medical Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 99 shares
@ $1.31, valued at
$129.7
Exercised 350 restricted stock units
@ $0 |
|
| 07/27/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Other Events Interactive Data |
| 06/15/2023 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| Patterson Matthew R (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| Poulton Jeffrey V. (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 06/15/2023 |
4
| REICIN ALISE (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/20/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/16/2023 |
3
| Jordan Julie (Chief Medical Officer) has filed a Form 3 on Homology Medicines, Inc. |
| 03/09/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/09/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/06/2023 |
4
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 10,965 shares
@ $1.4467, valued at
$15.9k
|
|
| 02/27/2023 |
4
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 164,000 options to buy
@ $1.6, valued at
$262.4k
Granted 27,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 104,000 options to buy
@ $1.6, valued at
$166.4k
Granted 17,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Smith W Bradford (See remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 213,000 options to buy
@ $1.6, valued at
$340.8k
Granted 36,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 632,000 options to buy
@ $1.6, valued at
$1M
Granted 105,000 restricted stock units
@ $0 |
|
| 01/20/2023 |
3/A
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 3/A on Homology Medicines, Inc. |
| 01/20/2023 |
4/A
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc. |
| 01/20/2023 |
4/A
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc. |
| 01/20/2023 |
4/A
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc. |
| 01/11/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 2,454 shares
@ $1.3904, valued at
$3.4k
|
|
| 01/11/2023 |
4
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 3,090 shares
@ $1.3903, valued at
$4.3k
|
|
| 01/11/2023 |
4
| Smith W Bradford (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 3,729 shares
@ $1.3912, valued at
$5.2k
|
|
| 01/11/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 3,620 shares
@ $1.3904, valued at
$5k
|
|
| 01/11/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 10,616 shares
@ $1.3905, valued at
$14.8k
|
|
| 01/04/2023 |
8-K
| Investor presentation |
| 01/04/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 2,640 restricted stock units
@ $0
Exercised 4,950 restricted stock units
@ $0 |
|
|